KOREA WHO
-
-
-
President and CEO of Boryung and Boryung Holdings
Kim Jung-gyun
Young Third-Generation Pharma Owner Bets on Space and Healthcare
-
Last Updated on Aug 7, 2026
-
President and CEO of Boryung and Boryung Holdings
Life Summary
Kim Jung-gyun is CEO of Boryung. He also serves as Chairman of Boryung’s board of directors and CEO of Boryung Holdings.
He is focusing on developing life science research infrastructure that uses the space environment into a long-term growth business.
He was born on August 29, 1985, as the son of Kim Eun-sun, Chairwoman of Boryung Holdings.
Kim Seung-ho, Honorary Chairman of Boryung Group, is his maternal grandfather.
He graduated from the University of Michigan in the United States with a degree in industrial engineering and earned a master’s degree in social and administrative pharmacy from Chung-Ang University’s Graduate School of Food and Drug Administration.
He worked at Samjong KPMG before joining Boryung. After working in strategic planning, production management and human resources, he took charge of overall management at Boryung Holdings.
He was appointed CEO of Boryung Holdings in 2019 and has also served as CEO of Boryung since 2022.
In 2026, he significantly strengthened his control over the group by becoming the largest shareholder of Boryung Holdings through the merger of Boryung Holdings and Boryung Partners.
#KimJunggyun #Boryung #BoryungHoldings #BoryungGroup #spacebusiness #lifesciences #spaceresearch #healthcare #corporategovernance #pharmaceuticalindustry
He is focusing on developing life science research infrastructure that uses the space environment into a long-term growth business.
He was born on August 29, 1985, as the son of Kim Eun-sun, Chairwoman of Boryung Holdings.
Kim Seung-ho, Honorary Chairman of Boryung Group, is his maternal grandfather.
He graduated from the University of Michigan in the United States with a degree in industrial engineering and earned a master’s degree in social and administrative pharmacy from Chung-Ang University’s Graduate School of Food and Drug Administration.
He worked at Samjong KPMG before joining Boryung. After working in strategic planning, production management and human resources, he took charge of overall management at Boryung Holdings.
He was appointed CEO of Boryung Holdings in 2019 and has also served as CEO of Boryung since 2022.
In 2026, he significantly strengthened his control over the group by becoming the largest shareholder of Boryung Holdings through the merger of Boryung Holdings and Boryung Partners.
#KimJunggyun #Boryung #BoryungHoldings #BoryungGroup #spacebusiness #lifesciences #spaceresearch #healthcare #corporategovernance #pharmaceuticalindustry